The number of people getting treatment for pre-exposure prophylaxis against the human immunodeficiency viruses (HIV) in France has been rising over the years. Among those who used such a treatment with Truvada or a generic equivalent between January 2016 and June 2019, 97.3 percent were men and 2.3 percent were women.
Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2019, by gender
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
ANSM. (November 1, 2019). Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2019, by gender [Graph]. In Statista. Retrieved May 20, 2022, from https://www.statista.com/statistics/1116567/hiv-aids-prep-users-france-gender/
ANSM. "Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2019, by gender." Chart. November 1, 2019. Statista. Accessed May 20, 2022. https://www.statista.com/statistics/1116567/hiv-aids-prep-users-france-gender/
ANSM. (2019). Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2019, by gender. Statista. Statista Inc.. Accessed: May 20, 2022. https://www.statista.com/statistics/1116567/hiv-aids-prep-users-france-gender/
ANSM. "Distribution of People Treated with Truvada® or Generic for Pre-exposure Prophilaxis (Prep) between January 2016 and June 2019, by Gender." Statista, Statista Inc., 1 Nov 2019, https://www.statista.com/statistics/1116567/hiv-aids-prep-users-france-gender/
ANSM, Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2019, by gender Statista, https://www.statista.com/statistics/1116567/hiv-aids-prep-users-france-gender/ (last visited May 20, 2022)
